Sunnybrook Health Science Centre
Toronto, Ontario, M4N 3M5, Canada
NCT Number: NCT03313674
Seasonal Affective Disorder (SAD) is a subtype of Major Depressive Disorder, characterized by a recurrent temporal relationship between the season of year, the onset and the remission of a major depressive episode. Estimates of the annual prevalence state that 1-6% of the population will develop SAD with the larger prevalences found at greater extremes in latitude. SAD is most likely triggered by the shortening photoperiod experienced in the winter months leading to a deterioration of mood. Recent cross-sectional neuroimaging studies have found cellular and neurotransmitter changes in response to seasonality, ultimately having an impact on the affect of patients. Conversly, this study aims to investigate the changes in neurocircuitry related to depression and euthymic states. Patients with SAD offer a unique ability to study these changes since they have predictable triggers for the onset of depression (i.e. the winter months) and remission (i.e. the summer months).
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Toronto, Ontario, M4N 3M5, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for SAD Cohort
Exclusion criteria
for SAD Cohort
Inclusion criteria
for Unipolar Depression Cohort contraindications
Exclusion criteria
for Unipolar Depression Cohort
Inclusion criteria
for Healthy Controls
Exclusion criteria
for Healthy Controls
Light box that emits light at 10,000 lux or higher and has been demonstrated to regulate circadian rhythm that is aberrant in the SAD population
Time frame: 12 months
Functional MRI Scan
Time frame: 12 months
Diffusion Tensor Imaging Scan
Time frame: 12 months
Trail Makers Test B will be used to measure executive function. Test is scored based on time to complete.Average time is 75 seconds, deficient time is >273 seconds
Time frame: 12 months
Digit Symbol Substitute Test will be used to measure concentration. Survey score is determined by the number of correct and incorrect responses
Time frame: 12 months
California Verbal Learning Test. Score is conducted based on a propriety software based on the number of correctly recalled words after a list is administrated.
Time frame: 12 months
Blood will be drawn to assess different serum metabolites depending on the season. One blood draw will be taken in Winter, one in the summer. Over 3300 metabolites will be acquired from a single sample.
Time frame: 12 months
Sigh-SAD measures Depressive Severity specifically in SAD patients. It contains 29 items, with the total score ranging from 0 to 29. Higher values in the scale indicate worse depression severity.
Of the 29 items, 21 question (adapted from the Hamilton Depression scale) are used to determine typical depression severity, with an additional eight items for the "atypical" symptoms which are presented in seasonal affective disorder. The final score is summed, with equal weighting, to give the total score.
Sunnybrook Health Sciences Centre
Other
Seasonal Affective Disorder: Exploratory Investigation of Seasonal Variations in Brain Structure and Connectivity as a Predictor for Depressive Severity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01292889
Behavior, Behavioral Symptoms
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT00006517
Behavior, Behavioral Symptoms
New York, United States
View Trial DetailsNCT00139997
Depressive Disorder, Depressive Disorder, Major
New Haven, Connecticut, United States
View Trial DetailsNCT03691792
Depressive Disorder, Mental Disorders
Burlington, Vermont, United States
View Trial Details